科华生物 (002022.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(科华生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 507,746,754.42563,328,080.82833,147,693.691,587,038,140.224,479,896,235.63482,431,179.94420,497,071.93
 营业收入(元) 507,746,754.42563,328,080.82833,147,693.691,587,038,140.224,479,896,235.63482,431,179.94420,497,071.93
二、营业总成本(元) 551,399,307.50593,187,305.89736,271,219.101,635,189,203.412,326,434,373.04437,987,328.51389,804,855.79
 营业成本(元) 295,942,661.42320,243,788.61442,543,620.30992,166,851.541,802,408,993.30276,456,030.57235,708,421.40
 研发费用(元) 61,319,942.7159,034,819.2465,812,039.4692,885,193.40116,277,933.8618,178,639.8223,151,990.75
 营业税金及附加(元) 2,901,587.023,360,376.103,836,571.349,322,983.5740,068,106.092,244,111.842,718,433.60
 销售费用(元) 95,383,759.80125,997,411.50128,490,377.04307,721,700.60305,434,249.1577,796,190.1374,415,371.04
 管理费用(元) 89,632,362.1097,173,138.7281,310,165.54228,246,698.60167,121,603.0852,396,054.0944,850,721.86
 财务费用(元) 6,218,994.45-12,622,228.2814,278,445.424,845,775.70-104,876,512.4410,916,302.068,959,917.14
  其中:利息费用(元) 11,182,533.5110,943,020.4410,245,731.7310,990,921.699,973,141.515,977,079.3613,118,578.27
  其中:利息收入(元) 3,795,564.3111,175,947.017,954,256.4114,338,364.5126,908,141.31786,140.212,331,403.49
 资产减值损失(元) -4,132,604.73-17,311,777.18813,568.20-248,124,811.24-2,584,928.10-31,322.177,817,364.19
 信用减值损失(元) -2,190,625.59-1,758,168.912,340,720.57-36,773,396.59-35,151,617.45-392,971.56-1,015,596.10
三、其他经营收益
 加:投资收益(元) 5,405,585.436,995,973.107,014,732.49----
 资产处置收益(元) 1,012,504.221,054,049.51-507,086.163,245,833.171,080,738.5635,084.76172,277.75
 其他收益(元) 16,562,491.8329,986,712.0110,547,704.41115,355,863.8774,600,412.28692,795.211,926,119.33
四、营业利润(元) -26,995,201.92-10,892,436.54117,086,114.10-210,548,711.232,191,406,467.8844,747,437.6739,592,381.31
 加:营业外收入(元) 168,391.28-46,924.56287,638.461,780,356.32696,273.79-7,926.2325,988.81
 减:营业外支出(元) 2,309,192.801,004,026.141,028,112.58472,380.651,771,804.33258,011.248,186.44
五、利润总额(元) -29,136,003.44-11,943,387.24116,345,639.98-209,240,735.562,190,330,937.3444,481,500.2039,610,183.68
 减:所得税费用(元) 98,362.207,426,976.5719,171,340.63-8,583,571.25324,538,401.2610,051,776.267,805,223.38
六、净利润(元) -29,234,365.64-19,370,363.8197,174,299.35-200,657,164.311,865,792,536.0834,429,723.9431,804,960.30
(一)按经营持续性分类
  持续经营净利润(元) -29,234,365.64-19,370,363.8197,174,299.35-200,657,164.311,865,792,536.0834,429,723.9431,804,960.30
(二)按所有权归属分类
  归属于母公司股东的净利润(元) -41,082,204.59-33,633,803.0654,761,876.98-221,191,539.071,145,605,670.4824,147,715.1322,283,233.48
  少数股东损益(元) 11,847,838.9514,263,439.2542,412,422.3720,534,374.76720,186,865.6010,282,008.819,521,726.82
 扣除非经常性损益后的净利润(元) -44,729,154.95-41,256,142.5048,141,247.97-232,302,162.371,139,877,905.9823,884,345.5920,897,598.99
七、每股收益
 一、基本每股收益(元) -0.08-0.070.11-0.432.230.050.04
 二、稀释每股收益(元) -0.08-0.070.11-0.392.100.060.05
八、其他综合收益(元) -7,814,153.2425,996,446.68-2,293,123.0912,010,169.73-1,496,168.551,457,969.57-3,339,242.76
 归属于母公司股东的其他综合收益(元) -4,891,983.2620,944,792.88-1,933,888.657,764,393.24-1,563,017.032,321,516.44-1,953,212.49
 归属于少数股东的其他综合收益(元) -2,922,169.985,051,653.80-359,234.444,245,776.4966,848.48-863,546.87-1,386,030.27
九、综合收益总额(元) -37,048,518.886,626,082.8794,881,176.26-188,646,994.581,864,296,367.5335,887,693.5128,465,717.54
 归属于母公司所有者的综合收益总额(元) -45,974,187.85-12,689,010.1852,827,988.33-213,427,145.831,144,042,653.4526,469,231.5720,330,020.99
 归属于少数股东的综合收益总额(元) 8,925,668.9719,315,093.0542,053,187.9324,780,151.25720,253,714.089,418,461.948,135,696.55
公告日期 2023-10-282023-08-172023-04-222023-03-232022-10-272022-08-262022-04-30
审计意见(境内) 标准无保留意见

前瞻产业研究院